Immunocellular Therapeutics Overview
- Founded
- 1987

- Status
- Public
- Employees
- 4

- Stock Symbol
- IMUC

- Share Price
- $0.75
- (As of Friday Closing)
Immunocellular Therapeutics General Information
Description
ImmunoCellular Therapeutics Ltd is a US-based clinical-stage biotechnology company. It is engaged in developing immune-based therapies for the treatment of cancers which can elicit an immune response against several antigens. The company has developed ICT-107, which is a dendritic cell (DC) immunotherapy for the treatment of newly diagnosed glioblastoma multiforme (GBM), which is a lethal type of brain cancer. It develops Immunotherapies for treating cancer in which a patient's own immune system is stimulated to target tumor antigens, which are molecular signals that the immune system uses to identify foreign bodies.
Contact Information
- 23622 Calabasas Road
- Suite 300
- Calabasas, CA 91302
- United States
Immunocellular Therapeutics Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.75 | $0.81 | $0.16 - $0.98 | 31.5K |
Immunocellular Therapeutics Financials Summary
In Thousands, USD |
TTM 30-Jun-2018 | FY 2017 31-Dec-2017 | FY 2016 31-Dec-2016 | FY 2015 31-Dec-2015 |
---|---|---|---|---|
EV | 5,871 | 5,116 | (5,895) | 7,652 |
Revenue | 0 | 0 | 0 | 0 |
EBITDA | (5,650) | (13,386) | (20,723) | (12,641) |
Net Income | (5,664) | (14,312) | (22,086) | (12,791) |
Total Assets | 3,829 | 7,009 | 16,890 | 30,082 |
Total Debt | 0 | 0 | 574 | 1,959 |
Immunocellular Therapeutics Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Immunocellular Therapeutics‘s full profile, request access.
Request a free trialImmunocellular Therapeutics Comparisons
Industry
0000000
0000 000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialImmunocellular Therapeutics Competitors (32)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Celgene | Formerly VC-backed | Summit, NJ | 0000 | 000.00 | 000000&0 | 000.00 |
0000 000000 | Formerly VC-backed | Santa Monica, CA | 000 | 00000 | 000000&0 | 00000 |
0000000000 0000000 | Venture Capital-Backed | Mont-Saint-Guibert, Belgium | 00 | 00000 | 00000000000 | 00000 |
0000000 0000000000 | Corporation | San Diego, CA | 00 | 00000 | 000000000 | 00000 |
00000000 000000000 | Formerly VC-backed | Newtown, PA | 00 | 00000 | 00000000 | 00000 |
Immunocellular Therapeutics Executive Team (6)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Gary Titus | Chairman & Board Member |
Immunocellular Therapeutics Board Members (17)
Name | Representing | Role | Since |
---|---|---|---|
0000 00000 | Immunocellular Therapeutics | Chairman & Board Member | 000 0000 |
0000 00 00 | Immunocellular Therapeutics | Board Member | 000 0000 |
00000 0000000 00.0 | Self | Board Member | 000 0000 |
Immunocellular Therapeutics Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial